A 60-year-old woman presents with refractory hypertension and psychosis, revealing a rare adrenal cortical carcinoma — an ...

Expert testimony was key to an endocrinologist's fate after a patient died from metastatic lung cancer & he was sued for ...

Treatment with the Avmapki Fakzynja Co-pack received accelerated FDA approval for previously treated low-grade serous ovarian ...

Fintel reports that on May 8, 2025, Maxim Group downgraded their outlook for Theriva Biologics (NYSEAM:TOVX) from Buy to Hold ...

Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions ...

New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment in ...

In this single-arm trial, the median overall survival (OS) observed was 4.0 months (95% CI: 2.5-7.2) among all 64 adults in the primary efficacy analysis based on the Kaplan-Meier estimate. The median ...

Phase 3 results show the investigational drug norucholic acid is superior to placebo in halting disease progression.